CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Revenue (TTM)
$0
Q1 Apr 2021
Net Income (TTM)
−$129.05M
−10.7% YoY
Q1 Apr 2021
EPS Diluted (TTM)
—
Q1 Apr 2021
Gross Margin
—
Q1 Apr 2021
Operating Margin
—
Q1 Apr 2021
Net Margin
—
Q1 Apr 2021
Free Cash Flow (TTM)
−$96.66M
Q1 Apr 2021
Cash
$113.98M
Q1 Apr 2021
Total Debt
$29.76M
Q1 Apr 2021
Shares Outstanding
47.91M sh
Q1 Apr 2021
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.